Osaic Holdings
CALA

Osaic Holdings’s Calithera Biosciences, Inc CALA Stock Holding History

Osaic Holdings’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-795
Closed -$4K – 7823
2022
Q1 		$4K Buy
795
+750
+1,667% +$7.66K ﹤0.01% 6680
2021
Q4 		$0 Hold
45
– – ﹤0.01% 7757
2021
Q3 		$2K Hold
45
– – ﹤0.01% 6946
2021
Q2 		$2K Hold
45
– – ﹤0.01% 6788
2021
Q1 		$2K Buy
45
+25
+125% +$1.46K ﹤0.01% 6567
2020
Q4 		$2K Hold
20
– – ﹤0.01% 6141
2020
Q3 		$1K Sell
20
-75
-79% -$6.54K ﹤0.01% 6139
2020
Q2 		$10K Buy
95
+55
+138% +$6.53K ﹤0.01% 5198
2020
Q1 		$4K Buy
+40
New +$4.76K ﹤0.01% 5487

Other funds holding CALA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCMG
TSP Capital Management Group Summit, New Jersey $410M AUM 71.81% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Osaic Holdings's CALA Position: Q2 2022 in Review

Osaic Holdings sold out of Calithera Biosciences, Inc (CALA) in Q2 2022, closing a stake of 795 shares — an estimated $4K sold.

Osaic Holdings first reported a position in CALA in Q1 2020 and held it in 9 quarters. The position peaked at $10K in Q2 2020. 28 funds tracked by Wall St. Rank hold CALA as of Q2 2022.

  • Osaic Holdings reported no remaining Calithera Biosciences, Inc position as of Q2 2022 after selling out during the quarter.
  • Osaic Holdings sold 795 Calithera Biosciences, Inc shares in Q2 2022, an estimated $4K.
  • Osaic Holdings first reported a position in Calithera Biosciences, Inc in Q1 2020 and held it in 9 quarters.
  • Osaic Holdings's Calithera Biosciences, Inc position peaked at $10K in Q2 2020.
  • 28 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q2 2022.

Based on Osaic Holdings's 13F filing for Q2 2022, filed 10 Aug 2022.